Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-10-08

Clinical Trial Update: Effects of Teriparatide or Denosumab on Bone in Postmenopausal Women With Osteoporosis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing teriparatide and denosumab for bone health in postmenopausal osteoporosis completed with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Forteo (teriparatide)
  • Prolia (denosumab)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Osteoporosis | Phase 4 | Status: COMPLETED | Results posted: 2015-10-08